Evidence map›Paper›PMID 20615556›Full record

ArticleJournal of neuroimmunology2010

Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Shekher Mohan, Randall L Davis, Udaya DeSilva, Craig W Stevens

Abstract readComparative Study
In one paragraph

Article in Journal of neuroimmunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shekher MohanDepartment of Pharmacology and Physiology, Oklahoma State University-Center for Health Sciences, 1111 West 17(th) Street, Tulsa, OK 74107, USA.
Randall L Davis
Udaya DeSilva
Craig W Stevens
Oklahoma State University Center for Health Sciences · USOklahoma State University · US

Funding

FUNCTIONAL EVOLUTION OF OPIOID RECEPTORSR15DA012448 · NIDA · OSU CENTER OF HEALTH SCIENCES · PI STEVENS, CRAIG W · 1999 to 2007
$497k
Attenuation of astroglial chemokine expression by beta-funaltrexamine: implicatioR15NS062664 · NINDS · OSU CENTER FOR HEALTH SCIENCES · PI DAVIS, RANDALL L · 2008 to 2008
$198k
NIDA NIH HHS DA 012448NIDA NIH HHS R15 DA012448NINDS NIH HHS NS 062664NINDS NIH HHS R15 NS062664
6 · The paper itself

Abstract

Treatment of SK-N-SH cells with morphine and interleukin-1beta (IL-1β) produced dual regulation of the mRNA for the human mu opioid receptor (MOR) protein. Morphine produced a decrease in the MOR mRNA while IL-1β increased it, as assessed by real-time quantitative PCR. These data were consistent with immunocytochemical studies of treated and untreated cells. Morphine-mediated down-regulation of MOR was blocked by naltrexone and IL-1β-induced up-regulation of MOR was blocked by interleukin-1 receptor type 1 antagonist. Immune-opioid crosstalk was examined by IL-1β and morphine co-treatment. These data are the first to show dual regulation of MOR in neuroblastoma cells.

Indexed as

Cell Line, TumorDown-RegulationHumansInterleukin-1betaMorphineNeuroblastomaReceptor Cross-TalkReceptors, Interleukin-1 Type IReceptors, Opioid, muRNA, MessengerUp-RegulationIL1R1 protein, humanInterleukin-1betaMorphineReceptors, Interleukin-1 Type IReceptors, Opioid, muRNA, Messenger

Identifiers

PMID20615556
PMCPMC2942958
OpenAlexW2048283799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.